10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

ABBOTT LABORATORIES

Ticker: ABT   Fiscal Year: 2012

Consolidated Statement of Earnings

Period Ending Dec 31, 2012 10-K (Filed: Feb 15, 2013)

(In Millions, except shares in Thousands)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2012Dec 31, 2011Dec 31, 2010
Net Sales
$
39,874
38,85135,167
Cost of products sold15,12015,54114,665
Research and development4,3224,1293,724
Acquired in-process and collaborations research and development288672313
Selling, general and administrative12,05912,75710,376
Total Operating Cost and Expenses31,78933,09929,079
 
Operating Earnings8,0855,7526,088
 
Interest expense592530553
Interest (income)(79)(85)(105)
Net loss on extinguishment of debt1,351
Net foreign exchange (gain) loss(8)(50)(11)
Other (income) expense, net(34)159(62)
Earnings Before Taxes6,2635,1995,713
 
Taxes on Earnings3004701,087
Net Earnings5,9634,7284,626
 
Basic Earnings Per Common Share (in dollars per share)3.763.032.98
Diluted Earnings Per Common Share (in dollars per share)3.723.012.96
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares)1,575,3781,557,6431,546,400
Dilutive Common Stock Options and Awards (in shares)16,4609,7469,622
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares)1,591,8381,567,3891,556,022
 
Outstanding Common Stock Options Having No Dilutive Effect (in shares)1,16626,78929,403
External Links 
ABBOTT LABORATORIES (ABT) Fiscal Year 2012
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip